Stimulus‐Responsive Nano‐Prodrug Strategies for Cancer Therapy: A Focus on Camptothecin Delivery DOI
Bingyang Chu,

Hanzhi Deng,

Ting Niu

и другие.

Small Methods, Год журнала: 2023, Номер 8(8)

Опубликована: Дек. 12, 2023

Camptothecin (CPT) is a highly cytotoxic molecule with excellent antitumor activity against various cancers. However, its clinical application severely limited by poor water solubility, easy inactivation, and severe toxicity. Structural modifications nanoformulations represent two crucial avenues for camptothecin's development. the potential further structural limited, camptothecin nanoparticles fabricated via physical loading have drawbacks of low drug leakage. Prodrug-based CPT shown unique advantages, including increased loading, reduced burst release, improved bioavailability, minimal toxic side effects. Stimulus-responsive nano-prodrugs that respond to endogenous or exogenous stimuli introducing activatable linkers achieve spatiotemporally responsive release at tumor site. This review comprehensively summarizes latest research advances in stimulus-responsive nano-prodrugs, preparation strategies, mechanisms, their applications cancer therapy. Special focus placed on mechanisms characteristics treatment. Furthermore, prodrugs are discussed. Finally, challenges future directions be valuable readers engaged prodrug expected.

Язык: Английский

Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy DOI
Shenwu Zhang, Jing Wang,

Zhiqiang Kong

и другие.

Biomaterials, Год журнала: 2022, Номер 282, С. 121433 - 121433

Опубликована: Фев. 19, 2022

Язык: Английский

Процитировано

185

Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review DOI Creative Commons
Bingqian Li,

Huili Shao,

Lei Gao

и другие.

Drug Delivery, Год журнала: 2022, Номер 29(1), С. 2130 - 2161

Опубликована: Июль 10, 2022

Chemotherapy drugs have been used for a long time in the treatment of cancer, but serious side effects are caused by inability drug to be solely delivered tumor when treating cancer with chemotherapy. Natural products attracted more and attention due antitumor effect multiple ways, abundant resources less effects. Therefore, combination natural active ingredients chemotherapy may an effective strategy, which can inhibit growth multidrug resistance, reduce drugs. Nano-drug co-delivery system (NDCDS) play important role This review provides comprehensive summary research status application prospect nano-delivery strategies drugs, aiming provide basis development anti-tumor

Язык: Английский

Процитировано

164

Advancement of cancer immunotherapy using nanoparticles-based nanomedicine DOI

Vemana Gowd,

Anas Ahmad,

Mohammad Tarique

и другие.

Seminars in Cancer Biology, Год журнала: 2022, Номер 86, С. 624 - 644

Опубликована: Апрель 1, 2022

Язык: Английский

Процитировано

83

Self-driven nanoprodrug platform with enhanced ferroptosis for synergistic photothermal-IDO immunotherapy DOI
Ping Huang, Yao Yang, Wenyan Wang

и другие.

Biomaterials, Год журнала: 2023, Номер 299, С. 122157 - 122157

Опубликована: Май 9, 2023

Язык: Английский

Процитировано

58

Nanotechnology-empowered strategies in treatment of skin cancer DOI

Jyoti Chandra,

Nazeer Hasan, Nazim Nasir

и другие.

Environmental Research, Год журнала: 2023, Номер 235, С. 116649 - 116649

Опубликована: Июль 13, 2023

Язык: Английский

Процитировано

42

Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy DOI Creative Commons
Shaomin Yan, Yu Gan, Huizhe Xu

и другие.

Frontiers in Bioengineering and Biotechnology, Год журнала: 2025, Номер 12

Опубликована: Янв. 8, 2025

Cancer is a major killer threatening modern human health and leading cause of death worldwide. Due to the heterogeneity complexity cancer, traditional treatments have limited effectiveness. To address this problem, an increasing number researchers medical professionals are working develop new ways treat cancer. Bacteria chemotaxis that can target colonize tumor tissue, as well activate anti-tumor immune responses, which makes them ideal for biomedical applications. With rapid development nanomedicine synthetic biology technologies, bacteria extensively used carriers drug delivery tumors, holds promise overcoming limitations conventional cancer treatment regimens. This paper summarizes examples anti-cancer drugs delivered by bacterial carriers, their strengths weaknesses. Further, we emphasize carrier systems in clinical translation.

Язык: Английский

Процитировано

2

Nano-delivery systems for food bioactive compounds in cancer: prevention, therapy, and clinical applications DOI
Ítalo Rennan Sousa Vieira, Carlos Adam Conté-Júnior

Critical Reviews in Food Science and Nutrition, Год журнала: 2022, Номер 64(2), С. 381 - 406

Опубликована: Авг. 8, 2022

Bioactive compounds represent a broad class of dietary metabolites derived from fruits and vegetables, such as polyphenols, carotenoids glucosinolates with potential for cancer prevention. Curcumin, resveratrol, quercetin, β-carotene have been the most widely applied bioactive in chemoprevention. Lately, many approaches to encapsulating components nano-delivery systems improved biomolecules' stability targeted delivery. In this review, we critically analyze compounds, including polymeric nanoparticles (NPs), solid lipid (SLN), nanostructured carriers (NLC), liposomes, niosomes, nanoemulsions (NEs) use therapy. Efficacy studies nanoformulations using cell lines vivo models updated human clinical trials are also discussed. Nano-delivery were found improve therapeutic efficacy molecules against various types (e.g., breast, prostate, colorectal lung cancer) mainly due antiproliferation pro-apoptotic effects tumor cells. Furthermore, some promised combination therapy standard chemotherapeutic agents, increased efficiency fewer side effects. These opportunities identified developed ensure more excellent safety novel herbal medicines enabling insights designing

Язык: Английский

Процитировано

46

Biomaterials That Induce Immunogenic Cell Death DOI
Di Li, Siqi Liu, Yang Ma

и другие.

Small Methods, Год журнала: 2023, Номер 7(5)

Опубликована: Апрель 28, 2023

Abstract The immune system takes part in most physiological and pathological processes of the body, including occurrence development cancer. Immunotherapy provides a promising modality for inhibition even cure During immunotherapy, immunogenic cell death (ICD) tumor cells induced by chemotherapy, radiotherapy, phototherapy, bioactive materials, so forth, triggers series cellular responses causing release tumor‐associated antigens damage‐associated molecular patterns, which ultimately activate innate adaptive responses. Among them, ICD‐induced biomaterials attract increasing conditions as benefit biosafety multifunctional modifications. This Review summarizes research progress inducing ICD via triggering endoplasmic reticulum oxidative stress, mitochondrial dysfunction, membrane rupture discusses application prospects ICD‐inducing clinical practice cancer immunotherapy.

Язык: Английский

Процитировано

40

Tumor Microenvironment Mediated Spermidine-Metal-Immunopeptide Nanocomplex for Boosting Ferroptotic Immunotherapy of Lymphoma DOI
Tianqi Nie, Hengyu Liu,

Zhengwen Fang

и другие.

ACS Nano, Год журнала: 2023, Номер 17(11), С. 10925 - 10937

Опубликована: Май 23, 2023

Immunotherapy as an alternative treatment strategy for B-cell lymphoma is undesirable because of tumor heterogeneity and immune surveillance. Spermidine (SPM), a regulator the microenvironment (TME), can facilitate release damage-associated molecular patterns (DAMPs) from cancer cells, promote recognition, thus alleviate surveillance in TME. Hence, this work, self-assembled spermidine-based metal-immunopeptide nanocomplexes (APP-Fe NCs; APP anti-programmed death ligand-1 peptide) with pH-responsive kinetics were prepared via flash nanocomplexation (FNC) technique based on noncovalent interaction between APP-SPM-dextran (DEX) sodium tripolyphosphate (TPP) coordination Fe3+ TPP. An vitro study suggested that APP-Fe NCs effectively induce strong oxidative stress mitochondrial dysfunction subsequently lead to ferroptosis cells by interfering homeostasis cells. Further investigation mice models demonstrated inhibited growth liver metastasis lymphomas. Mechanistically, triggering tissues, these spermidine-containing efficiently facilitated DAMPs ultimately reshaped TME enhance immunotherapy efficacy lymphoma. Combined its good histocompatibility facile preparation technique, regulation may hold potential cascade amplification combinative clinic.

Язык: Английский

Процитировано

31

A Dual‐Targeting Liposome Enhances Triple‐Negative Breast Cancer Chemoimmunotherapy through Inducing Immunogenic Cell Death and Inhibiting STAT3 Activation DOI
Kaipei Luo, Lu Yang, Chunmei Yan

и другие.

Small, Год журнала: 2023, Номер 19(40)

Опубликована: Июнь 1, 2023

Immunotherapy gains increasing focus in treating triple-negative breast cancer (TNBC), while its efficacy is greatly restricted owing to low tumor immunogenicity and immunosuppressive microenvironment (ITM). Herein, a LyP-1 chondroitin sulfate (CS) dual-modified liposome co-loaded with paclitaxel (PTX) cryptotanshinone (CTS), namely CS/LyP-1-PC Lip, engineered for TNBC chemoimmunotherapy via induction of immunogenic cell death (ICD) inhibition signal transducer activator transcript-3 (STAT3) activation. Lip enhances cellular uptake through p32 CD44 dual receptor-mediated endocytosis. Within the tumor, CS layer continuously detached by hyaluronidase release drugs. Subsequently, CTS sensitizes cytotoxicity PTX 4T1 cells. induces ICD cells facilitates infiltration cytotoxic T lymphocyte provoke immune response. Meanwhile, concomitant delivery inhibits STAT3 activation decrease regulatory cell, M2-type tumor-associated macrophage, myeloid-derived suppressor thus reversing ITM. Markedly, dual-targeting shows superior anti-tumor subcutaneous mice significant lung metastasis suppression model. Overall, this work offers feasible combination regimen promising nanoplatform development chemoimmunotherapy.

Язык: Английский

Процитировано

23